Harvard Health Blog

Aspirin for primary prevention of cardiovascular disease, part 2

By: Deepak Bhatt, MD, MPH, Editor in Chief, Harvard Heart Letter Well, it seems as though not even a week can go by without more data on aspirin! I recently reviewed the ARRIVE trial and the implications for primary prevention that is, trying to prevent heart attacks and strokes in otherwise healthy people. Since then, yet another large clinical trial the ASPREE study has come out questioning the use…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In